Obesity and lung cancer - is programmed death ligand-1 (PD-1L) expression a connection?

被引:1
|
作者
Galazka, Jakub Krzysztof [1 ]
Czeczelewski, Marcin [2 ]
Kucharczyk, Tomasz [3 ]
Szklener, Katarzyna [4 ]
Mandziuk, Slawomir [4 ]
机构
[1] Med Univ Lublin, Chair Clin Oncol & Chemotherapy, Students Sci Assoc, 8 Jaczewskiego St, PL-20954 Lublin, Poland
[2] Med Univ Lublin, Dept & Clin Intervent Radiol & Neuroradiol, Students Sci Assoc, Lublin, Poland
[3] Med Univ Lublin, Lab Immunol & Genet, Lublin, Poland
[4] Med Univ Lublin, Chair Clin Oncol & Chemotherapy, Lublin, Poland
关键词
programmed death ligand-1; lung cancer; obesity; oncology; pulmonology; obesitology; BODY-MASS INDEX; VITAMIN-D; MORTALITY; RISK;
D O I
10.5114/aoms/175470
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: In this retrospective study, the authors evaluated whether obesity -induced immunomodulation impacts the expression of programmed death ligand-1 (PD -1L) in lung cancer cells. Methods: A retrospective cross-sectional study was performed. The study included 67 patients. The data did not have a normal distribution. Results: For women, using ANOVA test (p = 0.050) with post -hoc analysis, a statistically significant difference in expression was found between women with overweight and women with normal weight (p = 0.040). Conclusions: Apart from the above, the authors did not find any statistically significant correlation between PD -1L expression on lung cancer cells and body mass index, either in the whole group or in histological subgroups.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 50 条
  • [21] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Aryakrishna S. Lathika
    S. Lakshmi
    Preethi T. Ramdas
    Aswin Kumar
    Susan Mathews
    John Joseph
    Aleyamma Mathew
    Francis V. James
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [22] PROGRAMMED DEATH RECEPTOR LIGAND-1 (PD-L1) EXPRESSION IN A THYMOMA TISSUE MICROARRAY (TMA)
    Padda, Sukhmani Kaur
    Riess, Jonathan W.
    Schwartz, Erich Jurgen
    Tian, Lu
    Kohrt, Holbrook Edwin
    Neal, Joel W.
    West, Robert
    Wakelee, Heather A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (10) : S212 - S212
  • [23] Programmed cell death ligand-1 (PD-L1) expression in desmoid tumors: a retrospective study
    Yildirim, A. N. Toksoz
    Akyurek, M.
    Okay, E.
    Zenginkinet, T.
    Iyetin, Y.
    Ozkan, K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (11) : 5223 - 5229
  • [24] Intratumoral Heterogeneity of Programmed Cell Death Ligand-1 (PD-L1) Expression in Lung Cancers - Assessment by Spiral Array
    Nakamura, Sayuri
    Hayashi, Kentaro
    Imaoka, Yuki
    Kitamura, Yuka
    Akazawa, Yuko
    Groen, Ruben
    Nagayasu, Takeshi
    Yamasaki, Naoya
    Tuchiya, Tomoshi
    Fukuoka, Junya
    MODERN PATHOLOGY, 2017, 30 : 486A - 486A
  • [25] Intratumoral Heterogeneity of Programmed Cell Death Ligand-1 (PD-L1) Expression in Lung Cancers - Assessment by Spiral Array
    Nakamura, Sayuri
    Hayashi, Kentaro
    Imaoka, Yuki
    Kitamura, Yuka
    Akazawa, Yuko
    Groen, Ruben
    Nagayasu, Takeshi
    Yamasaki, Naoya
    Tuchiya, Tomoshi
    Fukuoka, Junya
    LABORATORY INVESTIGATION, 2017, 97 : 486A - 486A
  • [26] Profile of programmed death ligand-1 (PD-L1) expression and PD-L1 gene amplification in Indonesian colorectal cancer patients.
    Budiyati, Akterono Dwi
    Putra, Teguh Pribadi
    Kusumo, Gita Dewi
    Rexana, Fritzie
    Kurniawan, Antonius
    Sudoyo, Aru Wisaksono
    Utomo, Ahmad Rusdan
    Utama, Andi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [27] Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade A Key Player Against Various Cancers
    Guan, Jian
    Lim, Khin Sandar
    Mekhail, Tarek
    Chang, Chung-Che
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (06) : 851 - 861
  • [28] Programmed death ligand-1 expression as immunotherapeutic target in sinonasal cancer
    Riobello, Cristina
    Vivanco, Blanca
    Reda, Sara
    Lopez-Hernandez, Alejandro
    Garcia-Inclan, Cristina
    Potes-Ares, Sira
    Cabal, Virginia N.
    Lopez, Fernando
    Luis Llorente, Jose
    Hermsen, Mario A.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (04): : 818 - 827
  • [29] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    LABORATORY INVESTIGATION, 2017, 97 : 475A - 475A
  • [30] Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
    Mino-Kenudson, Mari
    CANCER BIOLOGY & MEDICINE, 2016, 13 (02) : 157 - 170